|
TURQUOISE-III: SAFETY AND EFFICACY OF 12-WEEK RIBAVIRIN-FREE
TREATMENT FOR PATIENTS WITH HCV GENOTYPE 1B AND CIRRHOSIS
|
|
|
Reported by Jules Levin
15th International Symposium on Viral Hepatitis and Liver Disease, Berlin, Germany, 26 June 2015
Jordan J Feld, Christophe Moreno, Roger Trinh, Edward Tam, Stefan Bourgeois, Yves Horsmans, Magdy Elkhashab, David E Bernstein, Ziad Younes, Bo Fu, Andreas Pangerl, Nancy S Shulman, Fred Poordad
|
|
|
|
|
|
|